IT8848619A0 - Derivati di lisosfingolipidi - Google Patents

Derivati di lisosfingolipidi

Info

Publication number
IT8848619A0
IT8848619A0 IT8848619A IT4861988A IT8848619A0 IT 8848619 A0 IT8848619 A0 IT 8848619A0 IT 8848619 A IT8848619 A IT 8848619A IT 4861988 A IT4861988 A IT 4861988A IT 8848619 A0 IT8848619 A0 IT 8848619A0
Authority
IT
Italy
Prior art keywords
lysosphingolipids
derivatives
Prior art date
Application number
IT8848619A
Other languages
English (en)
Other versions
IT1235162B (it
Inventor
Della Valle Francesco
Romeo Aurelio
Original Assignee
Fidia Farmaceutici
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Farmaceutici filed Critical Fidia Farmaceutici
Publication of IT8848619A0 publication Critical patent/IT8848619A0/it
Priority to IT8848619A priority Critical patent/IT1235162B/it
Priority to DK589789A priority patent/DK589789A/da
Priority to DE68927821T priority patent/DE68927821T2/de
Priority to CA002004190A priority patent/CA2004190A1/en
Priority to EP89403309A priority patent/EP0373038B1/en
Priority to AT89403309T priority patent/ATE149506T1/de
Priority to IL92511A priority patent/IL92511A0/xx
Priority to NZ231590A priority patent/NZ231590A/xx
Priority to AU45664/89A priority patent/AU632771B2/en
Priority to NO89894819A priority patent/NO894819L/no
Priority to HU896336A priority patent/HU205365B/hu
Priority to HU913514A priority patent/HU209561B/hu
Priority to HU913514A priority patent/HU913514D0/hu
Priority to FI895766A priority patent/FI895766A0/fi
Priority to TW078109297A priority patent/TW204300B/zh
Priority to JP1314136A priority patent/JP3004297B2/ja
Priority to KR1019890017925A priority patent/KR910009631A/ko
Application granted granted Critical
Publication of IT1235162B publication Critical patent/IT1235162B/it
Priority to US07/916,257 priority patent/US5519007A/en
Priority to US08/628,344 priority patent/US5792858A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/04—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated
    • C07C215/06—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic
    • C07C215/10—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and acyclic with one amino group and at least two hydroxy groups bound to the carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C215/00—Compounds containing amino and hydroxy groups bound to the same carbon skeleton
    • C07C215/02—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C215/22—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
    • C07C215/24—Compounds containing amino and hydroxy groups bound to the same carbon skeleton having hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and acyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/20—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a carbon atom of an acyclic unsaturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
    • C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/01—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms
    • C07C255/19—Carboxylic acid nitriles having cyano groups bound to acyclic carbon atoms containing cyano groups and carboxyl groups, other than cyano groups, bound to the same saturated acyclic carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C07C323/50—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton
    • C07C323/51—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C323/57—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C323/58—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups containing thio groups and carboxyl groups bound to the same carbon skeleton having the sulfur atoms of the thio groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups with amino groups bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/06—Phosphorus compounds without P—C bonds
    • C07F9/08—Esters of oxyacids of phosphorus
    • C07F9/09—Esters of phosphoric acids
    • C07F9/10—Phosphatides, e.g. lecithin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • C07H15/10—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical containing unsaturated carbon-to-carbon bonds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
IT8848619A 1988-12-02 1988-12-02 Derivati di lisosfingolipidi IT1235162B (it)

Priority Applications (19)

Application Number Priority Date Filing Date Title
IT8848619A IT1235162B (it) 1988-12-02 1988-12-02 Derivati di lisosfingolipidi
DK589789A DK589789A (da) 1988-12-02 1989-11-23 Lysosphingolipid-derivater
DE68927821T DE68927821T2 (de) 1988-12-02 1989-11-29 Lysosphingolipid-Derivate
CA002004190A CA2004190A1 (en) 1988-12-02 1989-11-29 New lysosphingolipid derivitives
EP89403309A EP0373038B1 (en) 1988-12-02 1989-11-29 New lysosphingolipid derivatives
AT89403309T ATE149506T1 (de) 1988-12-02 1989-11-29 Lysosphingolipid-derivate
AU45664/89A AU632771B2 (en) 1988-12-02 1989-11-30 New lysosphingolipid derivatives
NZ231590A NZ231590A (en) 1988-12-02 1989-11-30 N-acyllysosphingolipids and pharmaceutical compositions thereof
IL92511A IL92511A0 (en) 1988-12-02 1989-11-30 Lysosphingolipid derivatives
FI895766A FI895766A0 (fi) 1988-12-02 1989-12-01 Foerfarande foer framstaellning av nya lysosfingolipider.
HU896336A HU205365B (en) 1988-12-02 1989-12-01 Process for producing lysosphingolipid derivatives and pharmaceutical compositions comprising such compounds
HU913514A HU209561B (en) 1988-12-02 1989-12-01 Process for preparing pharmaceutical preparations containing n-(dichloro-acetyl)-sphingosine or n-(dichloro-acetyl)-dihydro-sphingosine as active ingredients
HU913514A HU913514D0 (en) 1988-12-02 1989-12-01 Process for the production of medical preparations containing n-(dichloracetyl)-sphingosine or n-(dichloracetyl)-dihydrosphingosine as active agents
NO89894819A NO894819L (no) 1988-12-02 1989-12-01 Nye lysophingolipid-derivater.
TW078109297A TW204300B (it) 1988-12-02 1989-12-01
JP1314136A JP3004297B2 (ja) 1988-12-02 1989-12-02 リゾスフィンゴ脂質誘導体
KR1019890017925A KR910009631A (ko) 1988-12-02 1989-12-02 신규한 n-아실리조스핀고리피드와 그의 유도체 및 그의 제조방법
US07/916,257 US5519007A (en) 1988-12-02 1992-07-21 Lysosphingolipid derivatives
US08/628,344 US5792858A (en) 1988-12-02 1996-04-05 Lysosphingolipid derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8848619A IT1235162B (it) 1988-12-02 1988-12-02 Derivati di lisosfingolipidi

Publications (2)

Publication Number Publication Date
IT8848619A0 true IT8848619A0 (it) 1988-12-02
IT1235162B IT1235162B (it) 1992-06-22

Family

ID=11267672

Family Applications (1)

Application Number Title Priority Date Filing Date
IT8848619A IT1235162B (it) 1988-12-02 1988-12-02 Derivati di lisosfingolipidi

Country Status (16)

Country Link
US (2) US5519007A (it)
EP (1) EP0373038B1 (it)
JP (1) JP3004297B2 (it)
KR (1) KR910009631A (it)
AT (1) ATE149506T1 (it)
AU (1) AU632771B2 (it)
CA (1) CA2004190A1 (it)
DE (1) DE68927821T2 (it)
DK (1) DK589789A (it)
FI (1) FI895766A0 (it)
HU (3) HU209561B (it)
IL (1) IL92511A0 (it)
IT (1) IT1235162B (it)
NO (1) NO894819L (it)
NZ (1) NZ231590A (it)
TW (1) TW204300B (it)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1235011B (it) * 1988-07-26 1992-06-16 Fidia Farmaceutici Sintesi di derivati di glicosfingolipidi ed in particolare di gangliosidi utilizzabili per la preparazione di immunoadsorbenti ed adsorbenti per affinita' impiegabili per la purificazione di anticorpi e di tossine specifiche, e per uso diagnostico
US5466675A (en) * 1992-02-04 1995-11-14 Piljac; Goran Immunological activity of rhamnolipids
TW261533B (it) * 1992-07-16 1995-11-01 Kirin Brewery
FR2711138B1 (fr) * 1993-10-12 1995-11-24 Oreal Céramides, leur procédé de préparation et leurs applications en cosmétique et en dermopharmacie.
DE69433062T2 (de) * 1993-10-28 2004-06-17 Cosmoferm B.V. Ceramid i analoge auf basis von phytosphingosine
US5663151A (en) * 1994-03-04 1997-09-02 Bristol-Myers Squibb Company Sulfated α-glycolipid derivatives as cell adhesion inhibitors
US5651981A (en) * 1994-03-29 1997-07-29 Northwestern University Cationic phospholipids for transfection
DE69514306T2 (de) * 1994-04-27 2000-06-21 Dsm Nv Kurzkettige 2-hydroxycarbonsäurederivate von ceramiden
US6428999B1 (en) 1994-07-21 2002-08-06 Takara Shuzo Co., Ltd. Sphingolipid ceramide N-deacylase, methods for producing sphingolipids and sphingolipid derivatives, and spingolipid ceramide N-deacylase gene
EP0707063B1 (en) * 1994-07-21 1998-06-17 Takara Shuzo Co. Ltd. Glycolipid ceramide deacylase
JP4101320B2 (ja) * 1996-10-11 2008-06-18 高砂香料工業株式会社 一級アミド誘導体の製造方法
JP3485232B2 (ja) * 1997-01-31 2004-01-13 高砂香料工業株式会社 光学活性化合物及びその製造方法
US6063387A (en) * 1997-04-17 2000-05-16 Elizabeth Arden Co., Division Of Conopco, Inc. Anhydrous cosmetic composition with ceramides for firming skin
EP1159256A1 (en) * 1999-03-09 2001-12-05 Cosmoferm B.V. Sphingoid base derivatives and uses thereof
EP1435972B1 (en) 2001-08-29 2016-03-09 Seneb Biosciences Inc. Novel synthetic ganglioside derivatives and compositions thereof
FR2839310A1 (fr) * 2002-05-03 2003-11-07 Pasteur Institut Nouveau procede de preparation d' alpha-glycosylceramides, nouveaux derives alpha-glycosylceramide et leurs applications
ES2325260T3 (es) * 2003-01-20 2009-08-31 Nederlandse Organisatie Voor Toegepast-Natuurwetenschappelijk Onderzoek Tno Utilizacion de esfingolipidos para reducir los niveles de triacilglicerol y colesterol en el plasma.
NL1022443C2 (nl) 2003-01-20 2004-07-22 Tno Sphingolipiden voor verbetering van de samenstelling van de darmflora.
AU2004220087A1 (en) 2003-03-06 2004-09-23 Seneb Biosciences, Inc. Methods and compositions for the enzymatic synthesis of gangliosides
ATE500752T1 (de) * 2004-03-16 2011-03-15 Tno Verwendung von sphingolipiden bei der behandlung und vorbeugung von typ-2-diabetes mellitus, insulinresistenz und metabolismussyndrom
JP2008521888A (ja) 2004-11-30 2008-06-26 ネーデルランドセ オルガニサティエ フォール トエゲパストナトールヴェテンシャッペリク オンデルゾエク ティエヌオー 脂肪症の、又は肝毒性及びその後遺症の治療及び予防におけるスフィンゴ脂質
EP2410846B1 (en) 2009-03-25 2016-09-07 Seneb Biosciences, Inc. Glycolipids as treatment for disease
WO2018200931A1 (en) * 2017-04-28 2018-11-01 University Of Virginia Patent Foundation Compositions and methods for treating cancer
KR102640816B1 (ko) 2021-02-17 2024-02-23 곽영민 식별선이 구비된 파이프라인

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1171432B (it) * 1981-08-03 1987-06-10 Fidia Farmaceutici Amidi organiche derivate da lipidi azotati utilizzabili come farmaci
AU546872B2 (en) * 1982-06-16 1985-09-26 Unilever Plc Skin treatment compositions containing a fatty acid or ester
CH679209A5 (en) * 1983-12-05 1992-01-15 Solco Basel Ag New neutral glyco-sphingolipid derivs.
EP0146810A3 (de) * 1983-12-05 1987-05-13 Solco Basel AG Verfahren zur Herstellung von Sphingosinderivaten
DD261165A5 (de) * 1985-08-13 1988-10-19 Solco Basel Ag,Ch Neues verfahren zur herstellung von sphingosinderivaten
EP0212400B1 (de) * 1985-08-13 1992-01-02 Solco Basel AG Neues Verfahren zur Herstellung von Sphingosinderivaten
JPH0692349B2 (ja) * 1986-03-06 1994-11-16 和光純薬工業株式会社 光学活性不飽和アミノアルコール誘導体の新規な製法
US4937232A (en) * 1986-09-15 1990-06-26 Duke University Inhibition of protein kinase C by long-chain bases
US4816450A (en) * 1986-09-15 1989-03-28 Duke University Inhibition of protein kinase C by long-chain bases

Also Published As

Publication number Publication date
NZ231590A (en) 1992-12-23
EP0373038B1 (en) 1997-03-05
CA2004190A1 (en) 1990-06-02
US5519007A (en) 1996-05-21
IL92511A0 (en) 1990-08-31
DE68927821T2 (de) 1997-09-25
KR910009631A (ko) 1991-06-28
AU632771B2 (en) 1993-01-14
IT1235162B (it) 1992-06-22
TW204300B (it) 1993-04-21
EP0373038A3 (en) 1992-01-08
HU205365B (en) 1992-04-28
JP3004297B2 (ja) 2000-01-31
FI895766A0 (fi) 1989-12-01
NO894819D0 (no) 1989-12-01
DK589789A (da) 1990-06-03
DE68927821D1 (de) 1997-04-10
US5792858A (en) 1998-08-11
HU913514D0 (en) 1992-01-28
ATE149506T1 (de) 1997-03-15
AU4566489A (en) 1990-06-21
NO894819L (no) 1990-06-05
HUT52107A (en) 1990-06-28
DK589789D0 (da) 1989-11-23
HU209561B (en) 1994-07-28
EP0373038A2 (en) 1990-06-13
JPH02200691A (ja) 1990-08-08

Similar Documents

Publication Publication Date Title
IT8848619A0 (it) Derivati di lisosfingolipidi
IT1231481B (it) Derivati di furano
DE68925161D1 (de) Alkylavermectin-Derivate
DE68927948D1 (de) Trehalosderivate
IT1190385B (it) Derivati di etilendiamminomonoammidi
DK19789D0 (da) Dehydrocholcalciferolderivater
DE68927657T2 (de) Butynylaminderivate
DK80890A (da) Thien-triazol-diazepin-derivater
IT1231238B (it) Derivati ammidinici
DK486089D0 (da) Pyranobenzoxadiazolderivater
IT1203608B (it) Derivati di prolina
IT8848618A0 (it) Derivati di lisogangliosidi
IT8922396A0 (it) Derivati di macrolidi polienici
DE3824433A1 (de) Fluorcyclopropyl-derivate
DK160389A (da) Aryldionderivater
DK104489A (da) Anvendelse af triazolderivater
IT8948247A0 (it) Nuovi derivati di-lisogangliosidi
ATA155589A (de) Mitomycinphosphat-derivate
IT1249212B (it) Derivati diidropirimidotiazinici
IT1228882B (it) Derivati 4 demetossi antraciclinici
DK324489A (da) Substituerede azacyclohexylderivater
IT1183330B (it) Derivati di fenilpropargilammine
IT1241410B (it) Derivati triazolo-pirimidinici
DK322489A (da) 1-normonylderivater
ITMI913434A0 (it) Derivati di tetraidro-5-isochinolinsolfonammidi

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19950925